vimarsana.com

Page 2 - புனே தேசிய நிறுவனம் ஆஃப் வைராலஜி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Coronavirus: Covaxin Offers Protection From Beta, Delta Variants, Claims Early Study

COVID-19 vaccine Covaxin offers protection against Beta, Delta variants: early study - World News

2021-06-09 12:35:27 GMT2021-06-09 20:35:27(Beijing Time) Xinhua English NEW DELHI, June 9 (Xinhua) A joint study by researchers from Pune s National Institute of Virology, the Indian Council of Medical Research (ICMR) and Bharat Biotech has found that the country s indigenous COVID-19 vaccine, Covaxin, offers protection against the Beta (B.1.351) and the Delta (B.1.617.2) variants, local media reports said Wednesday. The Delta variant (B.1.617.2) was first found in India and is the dominant strain in the country. The strain caused the deadly second wave in the country. The Beta variant (B.1.351) was first discovered in South Africa. The study evaluated the neutralisation potential of sera collected from 20 COVID-19 recovered cases and 17 people vaccinated with two doses of Covaxin against Beta and Delta variants and compared it with the prototype D614G variant.

Covaxin protects against Delta, Beta variants of COVID-19, says study

We beat first wave, halted second, ready to face third: Yogi Adityanath

We beat first wave, halted second, ready to face third: Yogi Adityanath SECTIONS Last Updated: May 18, 2021, 12:21 PM IST Share Synopsis PM Narendra Modi last week had cautioned states about infections spreading through rural parts which lack public health infrastructure. TNN (This story originally appeared in on May 17, 2021)Chief Minister Yogi Adityanath asserted here on Sunday that the country’s largest state was able to arrest the second surge of Covid-19 and was prepared to face the challenge of the much-feared “third wave”. “We defeated the first wave, have got a grip on the second and are well prepared to face a third one as and when it comes,” the CM told reporters.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.